aluates Reports

$ 0.0

Automative

Global mRNA Vaccines for Infectious Diseases Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-19H10101

Global mRNA Vaccines for Infectious Diseases Market Insights Forecast to 2028

BUY CHAPTERS

Global mRNA Vaccines for Infectious Diseases Market Research Report 2025

Code: QYRE-Auto-19H10101

Report

July 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA Vaccines for Infectious Diseases Market Size

The global market for mRNA Vaccines for Infectious Diseases was valued at US$ 32470 million in the year 2024 and is projected to reach a revised size of US$ 38500 million by 2031, growing at a CAGR of 2.5% during the forecast period.

mRNA Vaccines for Infectious Diseases Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Infectious Diseases.

The mRNA Vaccines for Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Vaccines for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Vaccines for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of mRNA Vaccines for Infectious Diseases Market Report

Report Metric	Details
Report Name	mRNA Vaccines for Infectious Diseases Market
Accounted market size in year	US$ 32470 million
Forecasted market size in 2031	US$ 38500 million
CAGR	2.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Infectious Disease Vaccines Cancer Vaccines
Segment by Application	Infectious Disease Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccines for Infectious Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA Vaccines for Infectious Diseases Market growing?

Ans: The mRNA Vaccines for Infectious Diseases Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the mRNA Vaccines for Infectious Diseases Market size in 2031?

Ans: The mRNA Vaccines for Infectious Diseases Market size in 2031 will be US$ 38500 million.

Who are the main players in the mRNA Vaccines for Infectious Diseases Market report?

Ans: The main players in the mRNA Vaccines for Infectious Diseases Market are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

What are the Application segmentation covered in the mRNA Vaccines for Infectious Diseases Market report?

Ans: The Applications covered in the mRNA Vaccines for Infectious Diseases Market report are Infectious Disease, Cancer

What are the Type segmentation covered in the mRNA Vaccines for Infectious Diseases Market report?

Ans: The Types covered in the mRNA Vaccines for Infectious Diseases Market report are Infectious Disease Vaccines, Cancer Vaccines

Recommended Reports

Vaccines Market

Diagnostic Testing

Vaccine Delivery Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Infectious Disease Vaccines

1.2.3 Cancer Vaccines

1.3 Market by Application

1.3.1 Global mRNA Vaccines for Infectious Diseases Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Infectious Disease

1.3.3 Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Vaccines for Infectious Diseases Market Perspective (2020-2031)

2.2 Global mRNA Vaccines for Infectious Diseases Growth Trends by Region

2.2.1 Global mRNA Vaccines for Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 mRNA Vaccines for Infectious Diseases Historic Market Size by Region (2020-2025)

2.2.3 mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2026-2031)

2.3 mRNA Vaccines for Infectious Diseases Market Dynamics

2.3.1 mRNA Vaccines for Infectious Diseases Industry Trends

2.3.2 mRNA Vaccines for Infectious Diseases Market Drivers

2.3.3 mRNA Vaccines for Infectious Diseases Market Challenges

2.3.4 mRNA Vaccines for Infectious Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue

3.1.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue (2020-2025)

3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2020-2025)

3.2 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by mRNA Vaccines for Infectious Diseases Revenue

3.4 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio

3.4.1 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Infectious Diseases Revenue in 2024

3.5 Global Key Players of mRNA Vaccines for Infectious Diseases Head office and Area Served

3.6 Global Key Players of mRNA Vaccines for Infectious Diseases, Product and Application

3.7 Global Key Players of mRNA Vaccines for Infectious Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Vaccines for Infectious Diseases Breakdown Data by Type

4.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Type (2020-2025)

4.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2026-2031)

5 mRNA Vaccines for Infectious Diseases Breakdown Data by Application

5.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Application (2020-2025)

5.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America mRNA Vaccines for Infectious Diseases Market Size (2020-2031)

6.2 North America mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025)

6.4 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Vaccines for Infectious Diseases Market Size (2020-2031)

7.2 Europe mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025)

7.4 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size (2020-2031)

8.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2020-2025)

8.4 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America mRNA Vaccines for Infectious Diseases Market Size (2020-2031)

9.2 Latin America mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025)

9.4 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size (2020-2031)

10.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025)

10.4 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna Therapeutics

11.1.1 Moderna Therapeutics Company Details

11.1.2 Moderna Therapeutics Business Overview

11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction

11.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.1.5 Moderna Therapeutics Recent Development

11.2 CureVac

11.2.1 CureVac Company Details

11.2.2 CureVac Business Overview

11.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction

11.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.2.5 CureVac Recent Development

11.3 Translate Bio

11.3.1 Translate Bio Company Details

11.3.2 Translate Bio Business Overview

11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction

11.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.3.5 Translate Bio Recent Development

11.4 BioNTech

11.4.1 BioNTech Company Details

11.4.2 BioNTech Business Overview

11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction

11.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.4.5 BioNTech Recent Development

11.5 Sangamo Therapeutics

11.5.1 Sangamo Therapeutics Company Details

11.5.2 Sangamo Therapeutics Business Overview

11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction

11.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.5.5 Sangamo Therapeutics Recent Development

11.6 Argos Therapeutics

11.6.1 Argos Therapeutics Company Details

11.6.2 Argos Therapeutics Business Overview

11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction

11.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.6.5 Argos Therapeutics Recent Development

11.7 In-Cell-Art

11.7.1 In-Cell-Art Company Details

11.7.2 In-Cell-Art Business Overview

11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction

11.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.7.5 In-Cell-Art Recent Development

11.8 eTheRNA

11.8.1 eTheRNA Company Details

11.8.2 eTheRNA Business Overview

11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction

11.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.8.5 eTheRNA Recent Development

11.9 Ethris

11.9.1 Ethris Company Details

11.9.2 Ethris Business Overview

11.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction

11.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.9.5 Ethris Recent Development

11.10 Tiba Biotechnology

11.10.1 Tiba Biotechnology Company Details

11.10.2 Tiba Biotechnology Business Overview

11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction

11.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025)

11.10.5 Tiba Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

List of Tables

Table 1. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Infectious Disease Vaccines

Table 3. Key Players of Cancer Vaccines

Table 4. Global mRNA Vaccines for Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global mRNA Vaccines for Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2020-2025)

Table 8. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2026-2031)

Table 10. mRNA Vaccines for Infectious Diseases Market Trends

Table 11. mRNA Vaccines for Infectious Diseases Market Drivers

Table 12. mRNA Vaccines for Infectious Diseases Market Challenges

Table 13. mRNA Vaccines for Infectious Diseases Market Restraints

Table 14. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global mRNA Vaccines for Infectious Diseases Market Share by Players (2020-2025)

Table 16. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2024)

Table 17. Ranking of Global Top mRNA Vaccines for Infectious Diseases Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by mRNA Vaccines for Infectious Diseases Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of mRNA Vaccines for Infectious Diseases, Headquarters and Area Served

Table 20. Global Key Players of mRNA Vaccines for Infectious Diseases, Product and Application

Table 21. Global Key Players of mRNA Vaccines for Infectious Diseases, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2020-2025)

Table 25. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2026-2031)

Table 27. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Application (2020-2025)

Table 29. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Application (2026-2031)

Table 31. North America mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 46. Moderna Therapeutics Company Details

Table 47. Moderna Therapeutics Business Overview

Table 48. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product

Table 49. Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 50. Moderna Therapeutics Recent Development

Table 51. CureVac Company Details

Table 52. CureVac Business Overview

Table 53. CureVac mRNA Vaccines for Infectious Diseases Product

Table 54. CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 55. CureVac Recent Development

Table 56. Translate Bio Company Details

Table 57. Translate Bio Business Overview

Table 58. Translate Bio mRNA Vaccines for Infectious Diseases Product

Table 59. Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 60. Translate Bio Recent Development

Table 61. BioNTech Company Details

Table 62. BioNTech Business Overview

Table 63. BioNTech mRNA Vaccines for Infectious Diseases Product

Table 64. BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 65. BioNTech Recent Development

Table 66. Sangamo Therapeutics Company Details

Table 67. Sangamo Therapeutics Business Overview

Table 68. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product

Table 69. Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 70. Sangamo Therapeutics Recent Development

Table 71. Argos Therapeutics Company Details

Table 72. Argos Therapeutics Business Overview

Table 73. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product

Table 74. Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 75. Argos Therapeutics Recent Development

Table 76. In-Cell-Art Company Details

Table 77. In-Cell-Art Business Overview

Table 78. In-Cell-Art mRNA Vaccines for Infectious Diseases Product

Table 79. In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 80. In-Cell-Art Recent Development

Table 81. eTheRNA Company Details

Table 82. eTheRNA Business Overview

Table 83. eTheRNA mRNA Vaccines for Infectious Diseases Product

Table 84. eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 85. eTheRNA Recent Development

Table 86. Ethris Company Details

Table 87. Ethris Business Overview

Table 88. Ethris mRNA Vaccines for Infectious Diseases Product

Table 89. Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 90. Ethris Recent Development

Table 91. Tiba Biotechnology Company Details

Table 92. Tiba Biotechnology Business Overview

Table 93. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product

Table 94. Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2020-2025) & (US$ Million)

Table 95. Tiba Biotechnology Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. mRNA Vaccines for Infectious Diseases Picture

Figure 2. Global mRNA Vaccines for Infectious Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global mRNA Vaccines for Infectious Diseases Market Share by Type: 2024 VS 2031

Figure 4. Infectious Disease Vaccines Features

Figure 5. Cancer Vaccines Features

Figure 6. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global mRNA Vaccines for Infectious Diseases Market Share by Application: 2024 VS 2031

Figure 8. Infectious Disease Case Studies

Figure 9. Cancer Case Studies

Figure 10. mRNA Vaccines for Infectious Diseases Report Years Considered

Figure 11. Global mRNA Vaccines for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global mRNA Vaccines for Infectious Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global mRNA Vaccines for Infectious Diseases Market Share by Region: 2024 VS 2031

Figure 14. Global mRNA Vaccines for Infectious Diseases Market Share by Players in 2024

Figure 15. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by mRNA Vaccines for Infectious Diseases Revenue in 2024

Figure 17. North America mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America mRNA Vaccines for Infectious Diseases Market Share by Country (2020-2031)

Figure 19. United States mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe mRNA Vaccines for Infectious Diseases Market Share by Country (2020-2031)

Figure 23. Germany mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Region (2020-2031)

Figure 31. China mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America mRNA Vaccines for Infectious Diseases Market Share by Country (2020-2031)

Figure 39. Mexico mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Country (2020-2031)

Figure 43. Turkey mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 47. CureVac Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 48. Translate Bio Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 49. BioNTech Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 50. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 51. Argos Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 52. In-Cell-Art Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 53. eTheRNA Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 54. Ethris Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 55. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine Digital Data Logger Market Insights Forecast to 2030

Global Viral Vaccines Market Research Report 2025

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030

Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Trivalent Flu Vaccine Market Insights Forecast to 2030

Global Livestock Vaccine Market Research Report 2025

Vaccine Glass Vials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Attenuated Vaccine Market Research Report 2025

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Bordetella Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions